894 related articles for article (PubMed ID: 17707433)
1. Office management of pediatric primary nocturnal enuresis: a comparison of physician advised and parent chosen alternative treatment outcomes.
Diaz Saldano D; Chaviano AH; Maizels M; Yerkes EB; Cheng EY; Losavio J; Porten SP; Sullivan C; Zebold KF; Hagerty J; Kaplan WE
J Urol; 2007 Oct; 178(4 Pt 2):1758-61; discussion 1762. PubMed ID: 17707433
[TBL] [Abstract][Full Text] [Related]
2. Treatment of nocturnal enuresis in children with attention deficit hyperactivity disorder.
Chertin B; Koulikov D; Abu-Arafeh W; Mor Y; Shenfeld OZ; Farkas A
J Urol; 2007 Oct; 178(4 Pt 2):1744-7. PubMed ID: 17707010
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of desmopressin combined with alarm therapy for monosymptomatic nocturnal enuresis.
Leebeek-Groenewegen A; Blom J; Sukhai R; Van Der Heijden B
J Urol; 2001 Dec; 166(6):2456-8. PubMed ID: 11696811
[TBL] [Abstract][Full Text] [Related]
4. The role of bladder capacity in antidiuretic and anticholinergic treatment for nocturnal enuresis.
Radvanska E; Kovács L; Rittig S
J Urol; 2006 Aug; 176(2):764-8; discussion 768-9. PubMed ID: 16813940
[TBL] [Abstract][Full Text] [Related]
5. Combination of the enuresis alarm and desmopressin: second line treatment for nocturnal enuresis.
Kamperis K; Hagstroem S; Rittig S; Djurhuus JC
J Urol; 2008 Mar; 179(3):1128-31. PubMed ID: 18206924
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of a tertiary center enuresis population, with special emphasis on the relation among nocturnal diuresis, functional bladder capacity and desmopressin response.
Dehoorne JL; Walle CV; Vansintjan P; Raes AM; De Guchtenaere AR; Van Laecke E; Hoebeke P; Vande Walle JG
J Urol; 2007 Mar; 177(3):1130-7. PubMed ID: 17296432
[TBL] [Abstract][Full Text] [Related]
7. Sustainability of remission of pediatric primary nocturnal enuresis--comparison of remission using Try for Dry vs. non-Try for Dry treatment plans.
Saldano DD; Chaviano AH; Maizels M
Urol Nurs; 2008 Aug; 28(4):263-6. PubMed ID: 18771159
[TBL] [Abstract][Full Text] [Related]
8. [Results of a therapeutic strategy against monosymptomatic nocturnal enuresis].
Rodríguez do Forno A; Ariceta Iraola G
An Esp Pediatr; 2001 Jan; 54(1):38-43. PubMed ID: 11181193
[TBL] [Abstract][Full Text] [Related]
9. Evaluation and treatment of enuresis.
Ramakrishnan K
Am Fam Physician; 2008 Aug; 78(4):489-96. PubMed ID: 18756657
[TBL] [Abstract][Full Text] [Related]
10. The effect of desmopressin on renal water and solute handling in desmopressin resistant monosymptomatic nocturnal enuresis.
Kamperis K; Rittig S; Radvanska E; Jørgensen KA; Djurhuus JC
J Urol; 2008 Aug; 180(2):707-13; discussion 713-4. PubMed ID: 18554642
[TBL] [Abstract][Full Text] [Related]
11. Desmopressin and oxybutynin in monosymptomatic nocturnal enuresis: a randomized, double-blind, placebo-controlled trial and an assessment of predictive factors.
Montaldo P; Tafuro L; Rea M; Narciso V; Iossa AC; Del Gado R
BJU Int; 2012 Oct; 110(8 Pt B):E381-6. PubMed ID: 22313792
[TBL] [Abstract][Full Text] [Related]
12. [In which patients is the oxybutynin-desmopressin combination therapy indicated?].
Martín-Crespo R; Luque R
Cir Pediatr; 2003 Oct; 16(4):181-5. PubMed ID: 14677356
[TBL] [Abstract][Full Text] [Related]
13. The treatment of primary nocturnal enuresis in Malaysia.
Kanaheswari Y
Med J Malaysia; 2006 Dec; 61(5):608-15. PubMed ID: 17623963
[TBL] [Abstract][Full Text] [Related]
14. Comparison of long-term efficacy of desmopressin lyophilisate and enuretic alarm for monosymptomatic enuresis and assessment of predictive factors for success: a randomized prospective trial.
Önol FF; Guzel R; Tahra A; Kaya C; Boylu U
J Urol; 2015 Feb; 193(2):655-61. PubMed ID: 25158273
[TBL] [Abstract][Full Text] [Related]
15. Combination therapy for nocturnal enuresis with desmopressin and an alarm device.
Bradbury M
Scand J Urol Nephrol Suppl; 1997; 183():61-3. PubMed ID: 9165611
[TBL] [Abstract][Full Text] [Related]
16. Nocturnal enuresis. Treatment options.
Steele BT
Can Fam Physician; 1993 Apr; 39():877-80. PubMed ID: 8495145
[TBL] [Abstract][Full Text] [Related]
17. Poor compliance with primary nocturnal enuresis therapy may contribute to insufficient desmopressin response.
Van Herzeele C; Alova I; Evans J; Eggert P; Lottmann H; Nørgaard JP; Vande Walle J
J Urol; 2009 Oct; 182(4 Suppl):2045-9. PubMed ID: 19695639
[TBL] [Abstract][Full Text] [Related]
18. Failure of monotherapy in primary monosymptomatic enuresis: a combined desmopressin and propiverine treatment regimen improves efficacy outcomes.
Alloussi SH; Mürtz G; Gitzhofer S; Eichel R; Lang C; Madersbacher H; Strugala G; Alloussi S
BJU Int; 2009 Jun; 103(12):1706-12. PubMed ID: 19154456
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of treatments for nocturnal enuresis in a heterogeneous population.
Schulman SL; Colish Y; von Zuben FC; Kodman-Jones C
Clin Pediatr (Phila); 2000 Jun; 39(6):359-64. PubMed ID: 10879938
[TBL] [Abstract][Full Text] [Related]
20. The circadian defect in plasma vasopressin and urine output is related to desmopressin response and enuresis status in children with nocturnal enuresis.
Rittig S; Schaumburg HL; Siggaard C; Schmidt F; Djurhuus JC
J Urol; 2008 Jun; 179(6):2389-95. PubMed ID: 18433780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
